Emphysema is a progressive, debilitating lung disease in which the lung’s breathing sacs, or alveoli, enlarge, get thinner, and eventually are destroyed as the cells die off. It can be fatal, and there is currently no cure. New research at Boston Children’s Hospital, using lung cells and mouse models of emphysema, offers hope in the form of a small, engineered peptide molecule called PR1P.
- The male Y chromosome does more than we thought
- Ultrapotent compound may help treat C. diff, reduce recurrence
- High-performance single-atom catalysts for high-temperature fuel cells
- Novel neuroimaging study on dissociative symptoms reveals wounds of childhood trauma
- Historical racial & ethnic health inequities account for disproportionate COVID-19 impact